← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2021-04-21

Drug application

FDA Application #

ANDA212250

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HISUN PHARM HANGZHOU

Manufacturer

Hisun Pharmaceuticals USA, Inc.

First approval

2021-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown